Cutting-Edge Solutions for VTE Prophylaxis and DVT Treatment.
Inhixia by Techdow
When it comes to Techdow Pharma, it is about more than simply developing medicines; we are in the game to revolutionize the way conditions related to blood clots are treated.
From venous thromboembolism (VTE) to deep vein thrombosis (DVT) and pulmonary embolism (PE), our expertise strives to empower patients on their journey towards better health.
Introducing Inhixa the advanced Anticoagulant Solution for DVT Treatment and Prophylaxis and the gold standard in Low Molecular Weight (LMWH) treatment for adults!
Meticulously crafted with precision and care, Inhixa is your trusted ally in tackling the complexities of deep vein thrombosis (DVT) treatment and prophylaxis. Inhixa reduces the risk of clots that could cause problems like heart attacks or strokes.
Why choose Inhixa? Its proven effectiveness makes it a standout choice. Available in a versatile range of concentrations — 100, 80, 60, 40, and 20 milligrams — Inhixa offers precise dosing and easy administration to meet every patient’s unique needs.
Each pack comes with 2 prefilled syringes (PFS), ensuring a seamless experience for healthcare providers and patients alike.
Produced by Techdow, a leader in the industry, Inhixa represents innovation and quality backed by cutting-edge research and development.
























